A <i>de novo</i> loss‐of‐function <i>DYNC1H1</i> mutation in a patient with parkinsonian features and a favourable response to levodopa
Krzysztof Szczałuba(Medical University of Warsaw), Rafał Płoski(Medical University of Warsaw), Piotr Gasperowicz(Medical University of Warsaw), Kamila Czerska(Institute of Biochemistry and Biophysics, Polish Academy of Sciences), Ewa Pronicka(Children's Memorial Health Institute), Małgorzata Rydzanicz(Medical University of Warsaw), Joanna Kosińska(Medical University of Warsaw), Dorota Piekutowska‐Abramczuk(Children's Memorial Health Institute), Elżbieta Ciara(Children's Memorial Health Institute), Anna Biernacka(Medical University of Warsaw), Krystyna Szymańska(Medical University of Warsaw), Milena Laure‐Kamionowska(Mossakowski Medical Research Institute, Polish Academy of Sciences), Agnieszka Jacoszek(Medical University of Warsaw), Anna Walczak(Medical University of Warsaw)
Cited by 5
Related Papers
A gene (PEX) with homologies to endopeptidases is mutated in patients with X–linked hypophosphatemic rickets
|Nature Genetics|1995|1.1k
GJB2 Mutations and Degree of Hearing Loss: A Multicenter Study
|The American Journal of Human Genetics|2005|562
Autosomal-Recessive Mutations in SLC34A1 Encoding Sodium-Phosphate Cotransporter 2A Cause Idiopathic Infantile Hypercalcemia
|Journal of the American Society of Nephrology|2015|284
New perspective in diagnostics of mitochondrial disorders: two years’ experience with whole-exome sequencing at a national paediatric centre
|Journal of Translational Medicine|2016|233
Clinical implementation of RNA sequencing for Mendelian disease diagnostics
|Genome Medicine|2022|215